	Gastos De Venta Y Administración		Fecha
Acadia Pharmaceuticals	USD 124.9M	1.24M	2025-09
Akebia Therapeutics	USD 25.74M	1.93M	2025-03
ALKERMES	USD 171.77M	17.9M	2025-09
Alnylam Pharmaceuticals	USD 285.06M	22.47M	2025-12
Amarin	USD 17.94M	17.86M	2025-09
ANI Pharmaceuticals	USD 76.66M	5.11M	2025-09
BioMarin Pharmaceutical	USD 223.42M	8.86M	2025-09
Coherus Biosciences	USD 26.02M	8.57M	2025-03
Emergent BioSolutions	USD 182.8M	82.3M	2023-06
Exact Sciences	USD 491.64M	35.94M	2025-09
Exelixis	USD 123.02M	19.9M	2025-12
Glaxosmithkline	GBP 2.91B	817.89M	2025-09
Heron Therapeutics	USD 23.34M	4.18M	2024-09
Ionis Pharmaceuticals	USD 86.56M	4.04M	2025-09
Ironwood Pharmaceuticals	USD 33.33M	2.78M	2024-12
Lexicon Pharmaceuticals	USD 39.19M	7.13M	2024-06
Merck	USD 2.85B	215M	2025-12
Moderna	USD 308M	40M	2025-12
Myriad Genetics	USD 129M	1.3M	2025-09
Nektar Therapeutics	USD -0.18	0.07	2024-09
Neurocrine Biosciences	USD 301.8M	10.2M	2025-12
Pacira	USD 91.8M	14.6M	2025-09
Pfizer	USD 4.08B	894M	2025-12
PTC Therapeutics	USD 84.05M	1.22M	2025-09
Sanofi	EUR 2.75B	455M	2025-12
Sarepta Therapeutics	USD 77.11M	7.22M	2025-09
United Therapeutics	USD 152M	60.5M	2025-09
Vanda Pharmaceuticals	USD 39.28M	1.71M	2024-12
Xoma	USD 11M	2.54M	2024-06

Emergent BioSolutions Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.